|
|
Сonditions and diseases
AIDS/HIV ALS Alzheimer's Disease Anemia Anti-Aging Treatment Arterial Hypertension Autism Cancer Diabetes Treatment Eye Diseases Idiopathic Encephalopathy Ischemic Heart Disease Liver Diseases MD Treatment Multiple Sclerosis Treatment Parkinson Treatment Rheumatoid Arthritis SMA Ulcerative Colitis. Crohn’s Disease
News about stem cells
Stem cell treatment protects bone marrow from damaging chemotherapy effects in cancer patients
12 May
Stem cell therapy can protect cancer patients from damaging side-effects of chemotherapy, a new trial in the US suggests.
12 May
Stem cell therapy can protect cancer patients from damaging side-effects of chemotherapy, a new trial in the US suggests.
New Approach to Treating Muscular Dystrophy With Stem Cells
05 May
Scientists from the Lillehei Heart Institute (University of Minnesota) have developed a new efficient process of making muscle cells from human stem cells and for the first time ever effectively treated with these cells muscular dystrophy in a mice model.
05 May
Scientists from the Lillehei Heart Institute (University of Minnesota) have developed a new efficient process of making muscle cells from human stem cells and for the first time ever effectively treated with these cells muscular dystrophy in a mice model.
A New Brain Stem Cell Discovered
29 April
Adult brain contains stem cells, and Researchers at Lund University (Switzerland) found a new type of these cells.
All news
29 April
Adult brain contains stem cells, and Researchers at Lund University (Switzerland) found a new type of these cells.
Experience in Treatment of Patients Suffering from Leucosis and Solid Tumors by Fetal Stem Cells
Smikodub A.I., Snigir N.V., Radzievskaya L.V., Grinevich Y.A., Bendug G.D.
Observed were 16 patients with acute leukoses and neutropenia and 32 patients with solid tumors, among them 16 with cervical carcinoma subjected to combined radiotherapy, 13 children with osteogenic and chondroid sarcoma, and 3 children with Wilms tumor. Suspensions with high contents of stem cells of hemopoiesis were used for treatment with nucleated cells count at 50–300x106/ml, CFU-GM at 0.6–165x103, and CFU GEMM at 2.1–9.0x103.
Upon treatment, the patients better endured cytostatic therapy. Percentage of complications reduced. Positive dynamics of infection process involving neutropenia and hemorrhagic syndrome was observed. Substantial increase in the amounts of leukocytes, thrombocytes and erythrocytes in the peripheral blood was observed on the 11th and 13th day after stem cell transplantation. Despite continuing radiotherapy, peripheral blood indices improved during the second week in cervical carcinoma patients. In patients with solid tumors, the increase in the total amount of lymphocytes, T-lymphocytes, and NK-cells was also observed. Cell therapy caused no side effects.
Observed were 16 patients with acute leukoses and neutropenia and 32 patients with solid tumors, among them 16 with cervical carcinoma subjected to combined radiotherapy, 13 children with osteogenic and chondroid sarcoma, and 3 children with Wilms tumor. Suspensions with high contents of stem cells of hemopoiesis were used for treatment with nucleated cells count at 50–300x106/ml, CFU-GM at 0.6–165x103, and CFU GEMM at 2.1–9.0x103.
Upon treatment, the patients better endured cytostatic therapy. Percentage of complications reduced. Positive dynamics of infection process involving neutropenia and hemorrhagic syndrome was observed. Substantial increase in the amounts of leukocytes, thrombocytes and erythrocytes in the peripheral blood was observed on the 11th and 13th day after stem cell transplantation. Despite continuing radiotherapy, peripheral blood indices improved during the second week in cervical carcinoma patients. In patients with solid tumors, the increase in the total amount of lymphocytes, T-lymphocytes, and NK-cells was also observed. Cell therapy caused no side effects.